STOCKWATCH
·
Biotechnology: Commercial Physical & Biological Resarch
BuybackMay 7, 2026, 05:27 PM

IQVIA Board Approves $2B Increase in Share Buyback Authorization

AI Summary

IQVIA Holdings Inc. announced that its board of directors approved an additional $2 billion for its existing equity repurchase program. This increases the total remaining authorization to $3.2 billion. The program allows for flexibility in timing and amount of repurchases, with no set expiration date.

Key Highlights

  • IQVIA's board of directors authorized an additional $2 billion for its existing equity repurchase program.
  • The total remaining authorization for the share repurchase program is now $3.2 billion.
  • The repurchase program is flexible, with no obligation to repurchase a specific amount of common stock.
  • The timing and amount of repurchases will be determined by management based on market conditions and corporate requirements.
  • The program does not have an expiration date and may be modified or discontinued at any time.
IQV
Biotechnology: Commercial Physical & Biological Resarch
IQVIA HOLDINGS INC.

Price Impact